Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending October 7, 2023 (Week 40)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,293 32,999 1,140,231 1,283,273
New England 174 1,650 30,862 40,722
Connecticut - 430 1,155 9,563
Maine - 74 2,227 2,450
Massachusetts - 700 20,417 22,006
New Hampshire 47 82 2,197 2,219
Rhode Island 105 694 3,849 3,492
Vermont 22 37 1,017 992
Middle Atlantic 2,233 4,178 150,741 148,956
New Jersey - 789 26,419 25,743
New York (excluding New York City) 838 1,032 32,209 30,751
New York City 443 1,490 50,797 49,882
Pennsylvania 952 1,233 41,316 42,580
East North Central 1,880 4,622 149,926 176,554
Illinois 101 1,811 38,838 55,088
Indiana 433 856 24,192 26,077
Michigan 271 975 25,281 32,993
Ohio 687 1,213 42,424 42,336
Wisconsin 388 562 19,191 20,060
West North Central 863 2,082 70,487 78,930
Iowa 143 333 10,296 11,461
Kansas 115 280 6,659 10,984
Minnesota 85 497 16,389 17,195
Missouri 474 746 24,692 24,968
Nebraska - 246 6,910 7,459
North Dakota - 92 1,786 2,829
South Dakota 46 125 3,755 4,034
South Atlantic 4,089 7,719 254,322 285,371
Delaware 86 210 4,244 3,903
District of Columbia - 199 5,456 6,329
Florida 1,813 2,786 86,921 81,560
Georgia 642 1,550 51,705 56,894
Maryland U NC U 23,445
North Carolina 2 1,445 44,638 50,245
South Carolina 774 766 25,788 27,861
Virginia 730 976 32,233 31,620
West Virginia 42 106 3,337 3,514
East South Central 1,231 2,455 73,688 86,315
Alabama 667 972 26,454 24,065
Kentucky 427 554 12,806 14,097
Mississippi 137 487 14,178 18,281
Tennessee - 1,094 20,250 29,872
West South Central 583 4,800 151,094 181,864
Arkansas 203 435 13,113 13,992
Louisiana 344 844 27,770 28,362
Oklahoma 36 473 12,274 16,064
Texas - 3,106 97,937 123,446
Mountain 1,308 2,480 82,990 91,433
Arizona 456 866 30,740 32,117
Colorado 400 782 19,415 20,098
Idaho 7 148 4,328 4,521
Montana 35 93 2,451 3,227
Nevada 207 367 9,446 12,640
New Mexico 11 241 6,879 8,780
Utah 192 254 8,528 8,663
Wyoming - 51 1,203 1,387
Pacific 2,932 5,049 176,121 193,128
Alaska 67 121 3,205 4,188
California 2,161 4,112 145,995 149,899
Hawaii - 132 - 4,279
Oregon 307 382 11,685 12,184
Washington 397 590 15,236 22,578
U.S. Territories - 124 1,138 3,593
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 3,593
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 7 42 111
Total 15,295 33,085 1,141,411 1,286,977
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.